Cullinan Oncology, Inc. (CGEM) Tops Q4 EPS by 1c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q4 EPS of ($0.77), $0.01 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Iran Says Hormuz To Close, Citing Ceasefire Violation- Tasnim
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS